William Mack & Associates
CL icon

William Mack & Associates’s Colgate-Palmolive CL Stock Holding History

William Mack & Associates’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.97K Buy
+23
New +$2.08K ﹤0.01% 558

Other funds holding CL

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

William Mack & Associates's CL Position: Q3 2026 in Review

William Mack & Associates opened a new position in Colgate-Palmolive (CL) in Q3 2026: 23 shares worth $1.97K. The stake represents ﹤0.01% of the portfolio and ranks #558 among its holdings.

1,712 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • William Mack & Associates held 23 shares of Colgate-Palmolive worth $1.97K as of Q3 2026.
  • Colgate-Palmolive was a new William Mack & Associates position in Q3 2026.
  • Colgate-Palmolive made up ﹤0.01% of William Mack & Associates's portfolio in Q3 2026, its #558 holding.
  • 1,712 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.